Product
TTRNA-DC vaccines
Aliases
TTRNA-DC vaccines with GM-CSF
3 clinical trials
6 indications
Indication
Malignant GliomaIndication
High-Grade GliomaIndication
OligodendrogliomaIndication
Progressive OligodendrogliomaIndication
Diffuse Intrinsic Pontine GliomaIndication
Brainstem GliomaClinical trial
ACTION Trial: Adoptive Cellular Therapy Following Dose-Intensified Temozolomide in Newly-diagnosed Pediatric High-grade Gliomas (Phase I).Status: Active (not recruiting), Estimated PCD: 2026-05-01
Clinical trial
ADAGiO: Adoptive Cellular Therapy for the TreAtment of Recurrent OliGodendrogliOma (OG) Adult PatientsStatus: Not yet recruiting, Estimated PCD: 2027-12-01
Clinical trial
BRAVO: Newly-Diagnosed Brain Stem Gliomas Treated With Adoptive Cellular Therapy During Recovery From Focal Radiotherapy Alone or Focal Radiotherapy and Dose-intensified Temozolomide (Phase I)Status: Active (not recruiting), Estimated PCD: 2024-12-01